However, while these results showed some promise, glioblastoma is especially notable for high TDO2 expression, and IDO1 inhibition in the absence of TDO2 inhibition may well have limited efficacy of these compounds in treating glioblastoma. The gene discussed is IDO1; the disease is glioblastoma.